Microbix Biosystems (MBX) Competitors C$0.32 +0.01 (+1.61%) (As of 12:49 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades MBX vs. BCT, IPA, MDNA, ONC, COV, SCYB, COM, NVH, IGX, and SVAShould you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Oncolytics Biotech (ONC), Covalon Technologies (COV), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), and Sernova (SVA). These companies are all part of the "biotechnology" industry. Microbix Biosystems vs. BriaCell Therapeutics ImmunoPrecise Antibodies Medicenna Therapeutics Oncolytics Biotech Covalon Technologies Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Sernova BriaCell Therapeutics (CVE:BCT) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Is BCT or MBX more profitable? Microbix Biosystems has a net margin of 21.73% compared to BriaCell Therapeutics' net margin of 0.00%. Microbix Biosystems' return on equity of 20.04% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A N/A Microbix Biosystems 21.73%20.04%3.82% Does the MarketBeat Community believe in BCT or MBX? Microbix Biosystems received 30 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. Likewise, 70.71% of users gave Microbix Biosystems an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Microbix BiosystemsOutperform Votes7070.71% Underperform Votes2929.29% Do analysts prefer BCT or MBX? BriaCell Therapeutics currently has a consensus price target of C$15.00, indicating a potential upside of 41.51%. Given BriaCell Therapeutics' higher probable upside, equities research analysts clearly believe BriaCell Therapeutics is more favorable than Microbix Biosystems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Microbix Biosystems 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, BCT or MBX? Microbix Biosystems has higher revenue and earnings than BriaCell Therapeutics. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19Microbix BiosystemsC$23.36M1.81C$5.08MC$0.047.75 Does the media prefer BCT or MBX? In the previous week, BriaCell Therapeutics' average media sentiment score of 0.00 equaled Microbix Biosystems'average media sentiment score. Company Overall Sentiment BriaCell Therapeutics Neutral Microbix Biosystems Neutral Do insiders and institutionals have more ownership in BCT or MBX? 0.4% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryMicrobix Biosystems beats BriaCell Therapeutics on 12 of the 13 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Microbix Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$42.38MC$164.93MC$5.07BC$6.25BDividend Yield2.30%3.25%4.99%5.27%P/E Ratio7.75329.4783.5726.81Price / Sales1.8114,939.521,220.301,531.29Price / Cash4.1311.6739.4683.81Price / Book1.557.116.933.15Net IncomeC$5.08M-C$18.52MC$119.12MC$299.38M7 Day Performance-1.59%-0.29%-1.83%0.76%1 Month Performance-6.06%8.05%-3.64%12.82%1 Year Performance6.90%26.03%31.64%44.03% Microbix Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMicrobix BiosystemsN/AC$0.32+1.6%N/A+5.1%C$43.06MC$23.36M7.88N/ABCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownMDNAMedicenna TherapeuticsN/AC$1.50flatN/A+252.9%C$114.65MN/A-3.9520Gap UpONCOncolytics Biotech1.4019 of 5 starsC$1.39-0.7%C$3.50+151.8%-34.6%C$106.84MN/A-3.6829Analyst RevisionCOVCovalon TechnologiesN/AC$3.83-1.8%N/A+271.4%C$104.94MC$29.20M-97.50N/ASCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/A+0.0%C$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpSVASernovaN/AC$0.24flatC$1.83+663.9%-66.7%C$78.08MN/A-1.851,959Gap Down Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Medicenna Therapeutics Competitors Oncolytics Biotech Competitors Covalon Technologies Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors IntelGenx Technologies Competitors Sernova Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:MBX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbix Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
